Put the two prices on separate lines
QuickMD advertises a $79 doctor visit and a $59 cash-pay medication price for a thirty-day supply. The page explicitly says that the medication price excludes the visit. Adding those two figures gives a $138 illustration for a visit plus the listed supply, before any account-specific details are established. It is not a completed checkout or a guaranteed final total.
The thirty-day description is important. A $59 bottle price with no duration would be a different record from a stated thirty-day supply. Even so, a supply estimate does not prescribe an application amount or guarantee how long a container will last if the treatment instructions change. The clinician and dispensing pharmacy must clarify those instructions.
Our estriol price guide explains how to compare supply periods, and the price workspace can calculate an equivalent from an entered quote. Its arithmetic cannot decide whether the medicine is appropriate or whether another appointment will be required for a later refill.
A consultation does not guarantee a prescription
The page describes visits by video or phone and states that a doctor can prescribe only after the visit. It also says prescriptions are not guaranteed. A reader should therefore understand the visit as an assessment, not a purchase of an automatic prescription approval.
QuickMD advertises same-day appointment or prescribing availability. That does not prove that a particular time slot is available, that every applicant will qualify or that a shipment will arrive the same day. We did not test scheduling, the length of the consultation or response times for follow-up questions.
Ask what the visit covers, whether further information may be needed and how a concern requiring an in-person skin examination is handled. Our online photo guide describes what images can contribute to a consultation and what they cannot establish on their own.
The complete formulation remains a question
The retrieved page names estriol face cream but does not provide an exact strength and complete ingredient list sufficient to identify the dispensed preparation. This review does not infer a concentration from a competing brand or from the historical study a reader may have seen elsewhere. Estriol products can differ even when their names sound similar.
Request the active ingredients and strengths, the full base, quantity, container and dispensing pharmacy for the actual prescription. If the service proposes additional ingredients, ask how that changes the precautions and follow-up. A promotional image of a generic cream container is not a substitute for the dispensing record.
The prescription checklist helps keep these documents aligned. It is also useful if a refill arrives with a different label or dispenser. Knowing the brand name alone cannot determine the amount delivered by one press or click.
Do not turn absorption reassurance into a measurement
QuickMD's page describes the treatment as generally safe when prescribed and says only a small amount enters the rest of the body. We did not obtain exact-formula absorption data from that page. The wording should not be treated as a measured result for every preparation or as proof of zero systemic hormone exposure.
FDA states that there are no FDA-approved drugs containing estriol. It also explains that compounded medicines do not undergo the agency's premarket approval review of safety, effectiveness and quality. Those facts do not predict a specific person's outcome, but they prevent a prescription listing from being described as an approved estriol drug.
Our claims guide separates advertising, ingredient research and exact-product evidence. A clinician's assessment remains necessary even when a cream is applied to skin, and the review cannot establish the suitability of a proposed prescription from a general safety phrase.
Screening and intended use need a clear discussion
The provider lists medical-history issues that may make the cream unsuitable, including unexplained bleeding, certain cancers, clotting history and pregnancy. That list belongs to the provider's screening information; it is not a complete self-assessment tool. Tell the clinician about relevant diagnoses, symptoms and all other hormone treatments.
The page discusses facial and neck use while advising avoidance of the eye area in its directions. This review does not reproduce a personal application schedule or authorize a different location. If the intended area is unclear, ask the clinician and follow the actual prescription rather than an instruction borrowed from another product.
Our eye-cream and dry-eye guide explains why an appearance treatment near the eyes is not an ophthalmic medicine. Burning, gritty sensations or vision symptoms need an appropriate eye-care discussion, not an assumption that a facial hormone cream will address them.
Delivery, refills and follow-up are distinct records
QuickMD says prescriptions are fulfilled through QuickMD Home Delivery and advertises free shipping. We did not independently inspect the dispensing pharmacy, verify a particular shipment or establish delivery timing to every location. Confirm the dispensing contact and the route for a damaged or delayed order.
Also ask whether a follow-up visit is required for another supply, what that visit would cost and whether any recurring payment is authorized. The current page's first-visit and medication figures do not fully describe every possible later order. A lower medication price cannot be compared fairly with a bundled service until those additional components are clear.
If there is a suspected side effect or quality problem, contact the treating and dispensing teams. The reporting guide explains how records can also support an FDA report without claiming that a report proves causation. Billing support and clinical assessment have different roles.
What the public record supports
The documented offer has an identifiable visit price, a separate medicine price and a stated supply period. Important remaining details include the exact dispensed formula, pharmacy record, individual eligibility, refill requirements and final charge. We have not established a probability of cosmetic improvement or a comparative safety advantage.
The CoreAge Rx Time Out review provides another formula and commercial record to inspect. CoreAge receives sponsored first placement through common ownership and promotion by this publication. That position does not make QuickMD less appropriate for an individual, or establish that either product will produce a particular result.